331 related articles for article (PubMed ID: 28558869)
21. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
22. Effects of Taraxaci Herba (Dandelion) on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Lee SM; Lee SM; Song J
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674879
[TBL] [Abstract][Full Text] [Related]
23. Fatty Acids in Some Cooking Oils as Agents of Hormonal Manipulation in a Rat Model of Benign Prostate Cancer.
Oyelowo O; Okafor C; Ajibare A; Ayomide B; Dada K; Adelakun R; Ahmed B
Niger J Physiol Sci; 2019 Jun; 34(1):69-75. PubMed ID: 31449274
[TBL] [Abstract][Full Text] [Related]
24. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
25. Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia.
Kim KS; Yang HY; Chang SC; Kim YM; Lee KY; Lee BM; Kim HS
Int J Mol Med; 2018 Oct; 42(4):2260-2268. PubMed ID: 30015834
[TBL] [Abstract][Full Text] [Related]
26. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
27. Heat-Killed and Live
Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
[TBL] [Abstract][Full Text] [Related]
28. Gamma Irradiated
Xin Q; Kwon MJ; Lee JW; Kim KS; Chen H; Campos MG; Tundis R; Cui CB; Cho YH; Cao H
Molecules; 2019 Nov; 24(21):. PubMed ID: 31689885
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
Swaroop A; Bagchi M; Kumar P; Preuss HG; Bagchi D
Toxicol Mech Methods; 2015; 25(9):653-64. PubMed ID: 26337762
[TBL] [Abstract][Full Text] [Related]
30. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
[TBL] [Abstract][Full Text] [Related]
31. Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats.
Marghani BH; Fehaid A; Ateya AI; Ezz MA; Saleh RM
Life Sci; 2022 Feb; 291():120240. PubMed ID: 34942164
[TBL] [Abstract][Full Text] [Related]
32. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY
Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097
[TBL] [Abstract][Full Text] [Related]
33. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.
Said MM; Hassan NS; Schlicht MJ; Bosland MC
J Toxicol Environ Health A; 2015; 78(7):453-65. PubMed ID: 25785559
[TBL] [Abstract][Full Text] [Related]
34. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of ACTICOA powder, a cocoa polyphenolic extract, on experimentally induced prostate hyperplasia in Wistar-Unilever rats.
Bisson JF; Hidalgo S; Rozan P; Messaoudi M
J Med Food; 2007 Dec; 10(4):628-35. PubMed ID: 18158833
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of
Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
[No Abstract] [Full Text] [Related]
37. Chinese Skullcap (Scutellaria baicalensis Georgi) inhibits inflammation and proliferation on benign prostatic hyperplasia in rats.
Jin BR; Chung KS; Kim HJ; An HJ
J Ethnopharmacol; 2019 May; 235():481-488. PubMed ID: 30708034
[TBL] [Abstract][Full Text] [Related]
38. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
39. Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats.
Gong GY; Xi SY; Li CC; Tang WL; Fu XM; Huang YP
Phytomedicine; 2023 Nov; 120():155048. PubMed ID: 37651753
[TBL] [Abstract][Full Text] [Related]
40. Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Adaramoye OA; Akanni OO; Abiola OJ; Owumi SE; Akinloye O; Olapade-Olaopa EO
Biomed Pharmacother; 2017 Nov; 95():1493-1503. PubMed ID: 28946212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
